KR20230109692A - 혈소판 활성화 인자 수용체 길항제로서의 시클로펜타티오펜 카복스아미드 유도체 - Google Patents
혈소판 활성화 인자 수용체 길항제로서의 시클로펜타티오펜 카복스아미드 유도체 Download PDFInfo
- Publication number
- KR20230109692A KR20230109692A KR1020237020295A KR20237020295A KR20230109692A KR 20230109692 A KR20230109692 A KR 20230109692A KR 1020237020295 A KR1020237020295 A KR 1020237020295A KR 20237020295 A KR20237020295 A KR 20237020295A KR 20230109692 A KR20230109692 A KR 20230109692A
- Authority
- KR
- South Korea
- Prior art keywords
- alkyl
- optionally substituted
- group
- alkylene
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20207719 | 2020-11-16 | ||
| EP20207719.4 | 2020-11-16 | ||
| PCT/EP2021/081459 WO2022101377A1 (en) | 2020-11-16 | 2021-11-12 | Cyclopentathiophene carboxamide derivatives as platelet activating factor receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20230109692A true KR20230109692A (ko) | 2023-07-20 |
Family
ID=73543025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020237020295A Pending KR20230109692A (ko) | 2020-11-16 | 2021-11-12 | 혈소판 활성화 인자 수용체 길항제로서의 시클로펜타티오펜 카복스아미드 유도체 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US11766443B2 (https=) |
| EP (1) | EP4244229A1 (https=) |
| JP (2) | JP7465368B2 (https=) |
| KR (1) | KR20230109692A (https=) |
| CN (2) | CN116745300A (https=) |
| AR (1) | AR124070A1 (https=) |
| AU (1) | AU2021379248A1 (https=) |
| CA (1) | CA3200710A1 (https=) |
| CL (2) | CL2023001361A1 (https=) |
| CO (1) | CO2023005894A2 (https=) |
| CR (1) | CR20230211A (https=) |
| DO (1) | DOP2023000090A (https=) |
| EC (1) | ECSP23036210A (https=) |
| IL (1) | IL302769A (https=) |
| JO (1) | JOP20230107A1 (https=) |
| MX (1) | MX2023005678A (https=) |
| PE (1) | PE20231855A1 (https=) |
| SA (1) | SA523440809B1 (https=) |
| WO (1) | WO2022101377A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119842821A (zh) * | 2025-01-06 | 2025-04-18 | 华中科技大学 | 稳定表达血小板活化因子受体的细胞株、构建方法及应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3502392A1 (de) | 1985-01-25 | 1986-07-31 | Boehringer Ingelheim KG, 6507 Ingelheim | Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen |
| IE870123L (en) * | 1986-01-21 | 1987-07-21 | Boehringer Ingelheim Int | Thieno-1,4-diazepines |
| PH30676A (en) | 1986-07-22 | 1997-09-16 | Boehringer Ingelhein Kg | Hetrazepine compounds which have useful pharmaceutical utility |
| US4959361A (en) * | 1987-12-18 | 1990-09-25 | Hoffmann-La Roche Inc. | Triazolo(4,3-A)(1,4)benzodiazepines and thieno (3,2-F)(1,2,4)triazolo(4,3-A)(1,4)diazepine compounds which have useful activity as platelet activating factor (PAF) antagonists |
| MC1999A1 (fr) * | 1987-12-18 | 1990-01-26 | Hoffmann La Roche | Composes tricycliques |
| DE3909012A1 (de) | 1989-03-18 | 1990-09-20 | Boehringer Ingelheim Kg | Verbessertes verfahren zur herstellung von enantiomerenreinen hetrazepinen |
| DE4010528A1 (de) | 1990-04-02 | 1991-10-17 | Boehringer Ingelheim Kg | Praeparativ chromatographisches trennverfahren zur herstellung enantiomerenreiner hetrazepine |
| DE4132763A1 (de) | 1991-10-02 | 1993-04-08 | Boehringer Ingelheim Kg | Verbessertes verfahren zur herstellung von enantiomerenreinen saeureamiden hetrazepinoider struktur |
| FR2779652B1 (fr) | 1998-06-15 | 2001-06-08 | Sod Conseils Rech Applic | Utilisation de diazepines pour la preparation de medicaments destines a traiter les etats pathologiques ou les maladies dans lesquels un des recepteurs de la somatostatine est implique |
| US20050032713A1 (en) * | 2002-03-27 | 2005-02-10 | Wurtman Richard J. | Platelet-activating factor antagonists as analgesic, anti-inflammatory, uterine contraction inhibiting, and anti-tumor agents |
| CA2670031A1 (en) | 2006-11-20 | 2008-05-29 | Alantos Pharmaceuticals Holding, Inc. | Heterobicyclic metalloprotease inhibitors |
-
2021
- 2021-11-12 PE PE2023001605A patent/PE20231855A1/es unknown
- 2021-11-12 IL IL302769A patent/IL302769A/en unknown
- 2021-11-12 MX MX2023005678A patent/MX2023005678A/es unknown
- 2021-11-12 CN CN202180076849.5A patent/CN116745300A/zh active Pending
- 2021-11-12 AU AU2021379248A patent/AU2021379248A1/en active Pending
- 2021-11-12 CR CR20230211A patent/CR20230211A/es unknown
- 2021-11-12 EP EP21806745.2A patent/EP4244229A1/en active Pending
- 2021-11-12 KR KR1020237020295A patent/KR20230109692A/ko active Pending
- 2021-11-12 JP JP2022562298A patent/JP7465368B2/ja active Active
- 2021-11-12 CN CN202311341729.0A patent/CN117624188A/zh active Pending
- 2021-11-12 CA CA3200710A patent/CA3200710A1/en active Pending
- 2021-11-12 US US17/524,759 patent/US11766443B2/en active Active
- 2021-11-12 WO PCT/EP2021/081459 patent/WO2022101377A1/en not_active Ceased
- 2021-11-15 AR ARP210103159A patent/AR124070A1/es unknown
-
2023
- 2023-05-08 CO CONC2023/0005894A patent/CO2023005894A2/es unknown
- 2023-05-11 CL CL2023001361A patent/CL2023001361A1/es unknown
- 2023-05-11 DO DO2023000090A patent/DOP2023000090A/es unknown
- 2023-05-16 SA SA523440809A patent/SA523440809B1/ar unknown
- 2023-05-16 JO JOJO/P/2023/0107A patent/JOP20230107A1/ar unknown
- 2023-05-17 EC ECSENADI202336210A patent/ECSP23036210A/es unknown
- 2023-07-14 US US18/221,936 patent/US20230355638A1/en active Pending
-
2024
- 2024-02-01 CL CL2024000317A patent/CL2024000317A1/es unknown
- 2024-03-29 JP JP2024055696A patent/JP7810743B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN117624188A (zh) | 2024-03-01 |
| CR20230211A (es) | 2023-07-13 |
| CN116745300A (zh) | 2023-09-12 |
| US20220160725A1 (en) | 2022-05-26 |
| WO2022101377A1 (en) | 2022-05-19 |
| US20230355638A1 (en) | 2023-11-09 |
| CO2023005894A2 (es) | 2023-05-29 |
| ECSP23036210A (es) | 2023-06-30 |
| AR124070A1 (es) | 2023-02-08 |
| JP2024099528A (ja) | 2024-07-25 |
| TW202237620A (zh) | 2022-10-01 |
| JP7465368B2 (ja) | 2024-04-10 |
| MX2023005678A (es) | 2023-05-26 |
| US11766443B2 (en) | 2023-09-26 |
| JP7810743B2 (ja) | 2026-02-03 |
| CA3200710A1 (en) | 2022-05-19 |
| AU2021379248A9 (en) | 2024-10-10 |
| CL2024000317A1 (es) | 2024-07-12 |
| DOP2023000090A (es) | 2023-06-15 |
| JOP20230107A1 (ar) | 2023-05-16 |
| AU2021379248A1 (en) | 2023-06-22 |
| IL302769A (en) | 2023-07-01 |
| CL2023001361A1 (es) | 2023-11-03 |
| SA523440809B1 (ar) | 2024-10-08 |
| JP2023521200A (ja) | 2023-05-23 |
| PE20231855A1 (es) | 2023-11-21 |
| EP4244229A1 (en) | 2023-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3037986C (en) | Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator | |
| CA2672298C (en) | Fused pyridine compounds useful in the prophylaxis or treatment of viral infections | |
| KR20190020049A (ko) | Lpa 길항제로서의 카르바모일옥시메틸 트리아졸 시클로헥실 산 | |
| JP2021506859A (ja) | Ｌｐａアンタゴニストとしてのシクロヘキシル酸ピラゾールアジン | |
| JP6828191B2 (ja) | 血漿カリクレイン阻害剤としての複素芳香族カルボキサミド誘導体 | |
| CN112702998A (zh) | 作为lpa拮抗剂的环庚酸 | |
| WO2014101295A2 (zh) | 一种詹纳斯激酶（JAKs）抑制活性的异恶唑衍生物 | |
| JP2025500886A (ja) | 大環状ｂｔｋ阻害剤 | |
| JP2013522364A (ja) | 置換イミダゾ［１，２−ｂ］ピリダジン誘導体、医薬組成物、及びβ−セクレターゼ阻害剤としての使用の方法 | |
| WO2019154395A1 (zh) | 四氢异喹啉类化合物、其制备方法、包含此类化合物的药物组合物及其用途 | |
| KR20230122033A (ko) | Trpm3 매개 장애를 치료하기 위한 아릴 유도체 | |
| TWI873290B (zh) | 作為血漿激肽釋放酶抑制劑之雜芳族甲醯胺衍生物 | |
| TW201902887A (zh) | 做為血漿激肽釋放酶抑制劑之雜芳基甲醯胺衍生物 | |
| TW202421130A (zh) | 作為pi3k抑制劑的異喹啉酮 | |
| EP2513108B1 (fr) | NOUVEAUX DERIVES D' (HETEROCYCLE-PIPERIDINE CONDENSEE)-(PIPERAZINYL)-1-ALCANONE OU D' (HETEROCYCLE-PYRROLIDINE CONDENSEE)-(PIPERAZINYL)-1-ALCANONE ET LEUR UTILISATION COMME INHIBITEURS DE p75 | |
| JP7810743B2 (ja) | 血小板活性化因子受容体アンタゴニストとしてのシクロペンタチオフェンカルボキサミド誘導体 | |
| TWI913356B (zh) | 作為血小板活化因子受體拮抗劑之環戊烷并噻吩甲醯胺衍生物 | |
| CN119421883A (zh) | 用于治疗trpm3介导的病症的新型衍生物 | |
| EA048242B1 (ru) | Циклопентатиофенкарбоксамидные производные в качестве антагонистов рецептора фактора активации тромбоцитов | |
| JP2025501761A (ja) | 血小板活性化因子受容体アンタゴニストとしてのシクロペンタチオフェンカルボキサミド誘導体 | |
| CN121085992A (zh) | 信号转导及转录激活蛋白6选择性降解剂化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20230615 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20241107 Comment text: Request for Examination of Application |